What Is the Rhesus Gene and Why Does It Matter?

Whether your blood type ends in plus or minus comes down mostly to one gene, which either puts a particular protein on your red blood cells or leaves it off. For everyday life the difference is invisible, and being Rh-negative is not an illness. It becomes important when blood from someone with the protein meets blood from someone without it, which happens most often in pregnancy and transfusion.1PubMed Central. Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis The problem it can cause for babies, once a common cause of newborn death, is now largely preventable with a routine injection.2PubMed Central. Forty years of anti-D immunoprophylaxis3Parasitology. Toxoplasma and reaction time: role of toxoplasmosis in the origin, preservation and geographical distribution of Rh blood group polymorphism

What the Rh Gene Actually Does

Two side-by-side, near-identical genes on chromosome 1, called RHD and RHCE, make the Rh proteins.4PubMed Central. The genetics of the Rhesus blood group system. RHD makes a protein that carries the D antigen, a marker your immune system can read as “self” or “foreign.”5PubMed Central. The genetics of the Rhesus blood group system. RHCE makes related markers called C, c, E and e. These matter in some transfusions but have nothing to do with the plus or minus label, which refers only to the D antigen.6Wikipedia. Rh blood group system After ABO, no blood group marker matters more, because the D antigen is the one most likely to cause transfusion reactions and disease in newborns.7PubMed Central. The genetics of the Rhesus blood group system.

On a blood type, the plus or minus sits beside the ABO letters. “A positive” combines two separate systems, ABO and Rh D, and they are inherited independently, so any letter can be positive or negative. Your lab report or donor card may write “RhD neg” or “Rh-” for the same thing.

In most Rh-negative people the RHD gene is deleted altogether, so no D protein is made.8International Journal of Molecular Medicine. Molecular basis for the RhD negative phenotype in Chinese In one Taiwanese group, about 3 in 4 Rh-negative people had a missing RHD gene, while others had a broken or mixed-up version.9International Journal of Molecular Medicine. Molecular basis for the RhD negative phenotype in Chinese

The Rh proteins also have a job unrelated to blood typing. They help anchor the red cell’s outer layer to its inner scaffolding.10PubMed. Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation A partner protein in the Rh group helps move ammonia, a waste product, into red cells so it can be carried to the liver and kidneys.11PubMed Central. Human Rhesus-associated glycoprotein mediates facilitated transport of NH(3) into red blood cells12PubMed. Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter Rh-negative people lack only the D protein and stay healthy, because the rest of the Rh group is still made.

Most people only find out their type from a blood test, a donation or a pregnancy booking. Nothing about your health, fitness, diet or lifespan needs to change because of the minus sign.

Why Rh-Negative Matters in Pregnancy

An Rh-negative mother can carry an Rh-positive baby if the father passes on the RHD gene. During pregnancy, and especially at delivery, some of the baby’s red cells cross into the mother’s blood.13PubMed Central. Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis Extra crossing can happen with placental problems or an injury such as a fall or car accident.14PubMed Central. Fetomaternal hemorrhage: Pathogenesis, diagnosis, and clinical management Miscarriage, abortion or ectopic pregnancy can also expose the mother. Her immune system then treats the D protein as foreign and makes antibodies against it, called anti-D.15PubMed Central. Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis

This applies only when the mother is Rh-negative and the baby is Rh-positive. An Rh-positive mother has no risk from this, whatever the father’s type.

In a first Rh-positive pregnancy, the mother’s antibodies usually haven’t formed yet, because exposure mostly happens late, at delivery. That is why the first baby is usually spared and the risk grows with later Rh-positive babies. The first baby can still be at risk if she was already sensitised by an earlier event, such as a miscarriage or a past transfusion. And the risk is never certain, since not every Rh-negative mother exposed to Rh-positive cells makes antibodies.

Once made, the antibodies stay in the mother’s blood for good. In a later pregnancy with an Rh-positive baby, they cross the placenta and attack the baby’s red cells.16PubMed Central. Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis The baby can develop haemolytic disease of the fetus and newborn, where red cells are destroyed faster than they’re made.17PubMed Central. Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis Before modern prevention, this caused many fetal and newborn deaths or lasting harm.18Parasitology. Toxoplasma and reaction time: role of toxoplasmosis in the origin, preservation and geographical distribution of Rh blood group polymorphism

In a baby, mild cases cause jaundice, a yellowing of the skin and eyes, after birth. Moderate cases cause more marked jaundice and anaemia, which may need light therapy or a transfusion. Severe cases can cause swelling and heart strain before birth. Doctors monitor affected pregnancies with ultrasound and blood tests.

The mother usually feels completely well, since the antibodies cause her no symptoms. The problem shows up only in tests, which is why Rh-negative women are offered a blood antibody screen in pregnancy rather than waiting for signs. If antibodies are found, the pregnancy is followed more closely, with repeat antibody measurements. Finding them doesn’t mean the baby will be severely affected. Doctors judge that from how high the levels are and from scans.

How the Anti-D Shot Prevents the Problem

Anti-D immunoglobulin, often called RhoGAM or the anti-D shot, is an injection of ready-made anti-D antibodies. It removes the baby’s Rh-positive cells from the mother’s blood before her own immune system responds to them.19PubMed Central. Forty years of anti-D immunoprophylaxis Because her body never makes its own lasting antibodies, later babies are protected.20PubMed Central. Forty years of anti-D immunoprophylaxis Since its introduction in the late 1960s, cases of Rh sensitisation have dropped dramatically.21PubMed Central. Forty years of anti-D immunoprophylaxis

In a typical pregnancy, the shot is commonly given around 28 weeks, sometimes as two doses at 28 and 34 weeks. It is given again within 72 hours after birth if the baby is Rh-positive. It is also offered after bleeding, a fall, a miscarriage, amniocentesis, or an attempt to turn a breech baby. Each new pregnancy needs its own course.

After birth, the baby’s blood is tested, and the shot is given only if the baby is Rh-positive. If a dose is missed, tell your midwife or doctor straight away, because a late dose is still worth giving. Don’t assume the shot is unnecessary because there was no bleeding, since small exposures often cause no symptoms.

The shot goes into a muscle, usually in the upper arm or buttock, and feels like other routine injections. Common side effects are soreness at the site and, occasionally, a mild fever or aching. It is not a vaccine. It supplies borrowed antibodies that fade over weeks to months, which is why it is repeated in each pregnancy. Serious reactions are rare, and it is considered safe for the baby and for breastfeeding.

Current anti-D is made from donated human plasma, so supply depends on donors.22PubMed Central. Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies That plasma is screened and treated, and the shot has a long safety record. A lab-made version prevented sensitisation as well as the standard shot in one trial, with no mothers in either group making antibodies after 6 months.23PubMed Central. Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial

The shot can’t help once the mother already has her own anti-D antibodies. That is why an antibody screen early in pregnancy matters. If you’re unsure whether you had the shot in a past pregnancy, ask your midwife.

Testing to See if Your Baby Is Rh-Positive

Small fragments of the baby’s DNA circulate in the mother’s blood, so a sample from her arm can show whether the baby has the RHD gene.24PubMed. The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient-the time has come This cell-free DNA test needs only an ordinary blood draw, with no risk to the baby, unlike amniocentesis. It is usually done in the first half of pregnancy. The baby’s DNA is only detectable once enough has built up in the mother’s blood, so a test too early can be unreliable. Results can take days to a couple of weeks, depending on whether the lab is local.

In a large US group, the test correctly identified all 356 Rh-positive babies.25PubMed Central. Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort It called 295 of 297 Rh-negative babies correctly, wrongly flagging 2 as positive.26PubMed Central. Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort So a “baby Rh-negative” result is very reliable, and the rare errors lean toward giving a shot that wasn’t strictly needed, which is the safer mistake.

If the baby’s Rh blood test shows Rh-negative, some clinics skip the routine pregnancy shot. If it shows Rh-positive, the normal shot schedule goes ahead. Availability varies by country and clinic, so ask whether it’s offered. Testing of the baby’s cord blood after birth confirms the type.

Sometimes a result comes back inconclusive or “not detected.” The lab may then suggest repeating it or following the standard schedule. The test also doesn’t replace the antibody screen, since it says nothing about whether the mother has already made antibodies.

How Rh Is Inherited and How Common Rh-Negative Is

Everyone gets one RHD copy from each parent. One working copy is enough to be Rh-positive, so two Rh-positive parents who each carry a missing copy can have an Rh-negative child, with a 1 in 4 chance each pregnancy.

If the father is Rh-negative too, the baby will be Rh-negative. If he is positive, the baby could be either. An Rh-positive father may carry one or two working copies, and only two give an Rh-positive baby every time. If he carries one missing copy, each pregnancy has about a 1 in 2 chance of an Rh-negative baby. His type alone can’t tell you which, which is why the baby’s Rh blood test can be more useful than guessing. Paternity can’t always be certain either, so care plans focus on the mother’s type.

The share of people who are Rh-negative varies widely:

If you live somewhere your type is uncommon, Rh-negative blood may be in shorter supply locally. Donating helps keep stocks available for others with your type, and carrying a record of your blood type helps in emergencies.

Rh in Transfusions and Rare Rh Types

Rh-negative people given Rh-positive blood can make anti-D, so hospitals match Rh type.34PubMed Central. The genetics of the Rhesus blood group system. This matters most for girls and women who may become pregnant later. Rh-negative patients get Rh-negative blood whenever it is available. In an emergency with no matched blood, hospitals sometimes give Rh-positive blood to an Rh-negative person, then watch for antibodies and may plan follow-up. Rh-positive people can safely receive either type, as far as the D protein goes.

Some people make a weaker form of the D protein, which may appear on a report as “weak D.”35Clinical Laboratory. Molecular Biology of partial D and weak D: Implications for Blood Bank Practice The common weak D types in white Europeans have not caused antibody problems, and German guidelines treat them as Rh-positive.36Clinical Laboratory. Molecular Biology of partial D and weak D: Implications for Blood Bank Practice Rarer forms with even less D protein are treated as Rh-negative to be safe.37Clinical Laboratory. Molecular Biology of partial D and weak D: Implications for Blood Bank Practice A weak D result usually comes from the lab noticing that the D protein is faint, rather than from anything wrong with you. What it means for pregnancy depends on the exact type, so some women are treated as Rh-positive and others get the shot. Until the type is settled, many hospitals take the cautious route and treat you as Rh-negative for the shot and transfusion. If your report says weak D, ask whether genetic testing has shown which type you have, since that can change whether you need the shot.

A very few people have no Rh proteins at all, a type called Rh-null.38PubMed. Rh(null) phenotype: molecular basis, serologic features, clinical manifestations, and transfusion challenges-a scoping review of published cases Because Rh proteins help hold red cells together, these cells are fragile and often break down, causing ongoing anaemia.39PubMed Central. First Report of Known Rare Rhnull Phenotype Individuals in Iran40PubMed. Rh(null) phenotype: molecular basis, serologic features, clinical manifestations, and transfusion challenges-a scoping review of published cases Finding matching blood is very hard, relying on relatives, frozen stores or rare-donor registries.41PubMed. Rh(null) phenotype: molecular basis, serologic features, clinical manifestations, and transfusion challenges-a scoping review of published cases